Biosimilars in North America
暂无分享,去创建一个
[1] H. Löfgren. The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy. , 2007, Australia and New Zealand health policy.
[2] Jinyun Sun,et al. Emerging Economy Copycats: Capability, Environment, and Strategy , 2011 .
[3] Jan W. Rivkin. Imitation of Complex Strategies , 2000 .
[4] David C. Mowery,et al. Sources of Industrial Leadership: Explaining Industrial Leadership , 1999 .
[5] J. Fuhr,et al. The economics of biosimilars. , 2013, American health & drug benefits.
[6] W. Hall,et al. Assessing the impact of prescribed medicines on health outcomes , 2007, Australia and New Zealand health policy.
[7] Steven Kozlowski,et al. Developing the nation's biosimilars program. , 2011, The New England journal of medicine.
[8] J. Niosi. Biotechnology: a case of delayed international convergence? , 2014 .